Back
SOPHiA GENETICS SA Vs. Corbus Pharmaceuticals Holdings, Inc. Industry Stock Comparison
Buy
54
SOPH
SOPHiA GENETICS SA
Last Price:
$4.65
Seasonality Move:
5.53%
Sell
30
CRBP
Corbus Pharmaceuticals Holdings, Inc.
Last Price:
$8.21
Seasonality Move:
58.11%
Buy
54
SOPHiA GENETICS SA (SOPH)
is a Buy
Is SOPHiA GENETICS SA a Buy, Sell or Hold?
-
The current SOPHiA GENETICS SA [SOPH] share price is $4.73. The Score for SOPH is 54, which is 8% above its historic median score of 50, and infers lower risk than normal.
-
SOPH is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
30
Corbus Pharmaceuticals Holdings, Inc. (CRBP)
is a Sell
Is Corbus Pharmaceuticals Holdings, Inc. a Buy, Sell or Hold?
-
The current Corbus Pharmaceuticals Holdings, Inc. [CRBP] share price is $8.33. The Score for CRBP is 30, which is 40% below its historic median score of 50, and infers higher risk than normal.
-
CRBP is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
SOPH Stock Price Chart
What is SOPHiA GENETICS SA's stock price today?
-
The SOPHiA GENETICS SA share price today is $4.73Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and SOPH is experiencing buying pressure, which is a positive indicator for future bullish movement.
CRBP Stock Price Chart
What is Corbus Pharmaceuticals Holdings, Inc.'s stock price today?
-
The Corbus Pharmaceuticals Holdings, Inc. share price today is $8.33Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and CRBP is experiencing slight selling pressure.
SOPH Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 1.28 | Buy |
| Relative Strength Index (14 RSI): | 51.84 | Buy |
| Chaikin Money Flow: | 32551 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (4.52 - 4.96) | Sell |
| Bollinger Bands (100): | (3.48 - 4.72) | Buy |
CRBP Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -1 | Sell |
| Relative Strength Index (14 RSI): | 30.88 | Sell |
| Chaikin Money Flow: | -49339 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (8.78 - 11.38) | Sell |
| Bollinger Bands (100): | (8.74 - 14.48) | Sell |
SOPH Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 4.7 | Buy |
| 20-day SMA: | 4.78 | Sell |
| 50-day SMA: | 4.57 | Buy |
| 200-day SMA: | 3.61 | Buy |
| 8-day EMA: | 3.88 | Buy |
| 20-day EMA: | 2.36 | Buy |
| 50-day EMA: | 1.14 | Buy |
| 200-day EMA: | 0.32 | Buy |
CRBP Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 8.45 | Sell |
| 20-day SMA: | 9.69 | Sell |
| 50-day SMA: | 12.2 | Sell |
| 200-day SMA: | 9.51 | Sell |
| 8-day EMA: | 8.61 | Sell |
| 20-day EMA: | 9.52 | Sell |
| 50-day EMA: | 10.74 | Sell |
| 200-day EMA: | 7.51 | Buy |
SOPHiA GENETICS SA Earnings Growth & SOPH Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.01 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.29 per share, and an increase next year of $0.16 per share.
Corbus Pharmaceuticals Holdings, Inc. Earnings Growth & CRBP Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.26 per share, a decrease next quarter of $0.00 per share, a decrease this year of $2.34 per share, and an increase next year of $1.49 per share.
SOPHiA GENETICS SA Technical Analysis
| Dec 12 | Dec 15 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | Dec 22 | Dec 23 | Dec 24 | Dec 26 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 12 | 15 | 16 | 17 | 18 | 19 | 22 | 23 | 24 | 26 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Corbus Pharmaceuticals Holdings, Inc. Technical Analysis
| Dec 11 | Dec 12 | Dec 15 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | Dec 22 | Dec 24 | Dec 26 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 11 | 12 | 15 | 16 | 17 | 18 | 19 | 22 | 24 | 26 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||